Plant Michael P. 4

4 · Atlanta Braves Holdings, Inc. · Filed Dec 8, 2025

Form 4

Period: 2025-12-04

EVP, Development

Transactions

Exercise/Conversion
Series C Common Stock
2025-12-04+20,000→ 248,218 total
Sale
Series C Common Stock
2025-12-05$38.65/sh−8,893$343,714→ 239,325 total
Exercise/Conversion
Restricted Stock Units - BATRK
2025-12-04−20,000→ 0 total
From: 2025-12-04Exp: 2025-12-04→ Series C Common Stock (20,000 underlying)
Award
Restricted Stock Units - BATRK
2025-12-04+20,731→ 20,731 total
From: 2026-12-04Exp: 2026-12-04→ Series C Common Stock (20,731 underlying)

Holdings

Footnotes (5)

[F1]Each restricted stock unit converted into one share of Series C Common Stock.
[F2]Reflects 22,625 shares of Series C Common Stock previously held indirectly by the reporting person through his Grantor Retained Annuity Trust ("GRAT") and subsequently returned to the reporting person in satisfaction of the GRAT's annuity obligation.
[F3]The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.
[F4]Reflects the weighted average sale price. The range of prices for such transaction is $38.43 to $38.81. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
[F5]Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock.

Documents

1 file